MWAM
IDXG

Mariner Wealth Advisors (Madison)’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Mariner Wealth Advisors (Madison)’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$14K Hold
30
– – 0.01% 133
2013
Q2 		$14K Buy
+30
New +$13.6K 0.01% 102

Other funds holding IDXG

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KSC
Kendall Square Capital San Francisco, California $4.92M AUM 2.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
LCM
Leonard Capital Management Vero Beach, Florida $5.25M AUM

Mariner Wealth Advisors (Madison)'s IDXG Position: Q3 2013 in Review

Mariner Wealth Advisors (Madison) held its Interpace Biosciences, Inc. Common Stock (IDXG) position steady in Q3 2013 at 30 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #133.

Mariner Wealth Advisors (Madison) first reported a position in IDXG in Q2 2013 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold IDXG as of Q3 2013.

  • Mariner Wealth Advisors (Madison) held 30 shares of Interpace Biosciences, Inc. Common Stock worth $14K as of Q3 2013.
  • Mariner Wealth Advisors (Madison) left its Interpace Biosciences, Inc. Common Stock share count unchanged in Q3 2013.
  • Interpace Biosciences, Inc. Common Stock made up 0.01% of Mariner Wealth Advisors (Madison)'s portfolio in Q3 2013, its #133 holding.
  • Mariner Wealth Advisors (Madison) first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and has held it in 2 quarters since.
  • 29 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q3 2013.

Based on Mariner Wealth Advisors (Madison)'s 13F filing for Q3 2013, filed 14 Nov 2013.